IR CANCELLED; US REGISTRATION CANCELLED
on 15 Dec 2016
Last Applicant/ Owned by
Minato-ku; Tokyo 107-0052
JP
Serial Number
79034631 filed on 15th Dec 2006
Registration Number
3395110 registered on 11th Mar 2008
Correspondent Address
14-1, Toranomon 1-chome,
Minato-ku
Tokyo 105-0001, Japan
Filing Basis
No Filing Basis
Disclaimer
NO DATA
OSALEUKIN
Anticancer drugs; antitumor drugs; antineoplastic drugs; drugs for medical purposes, namely, Retinoic acid Receptor agonist for the treatment of autoimmune/inflammatory diseases, vascular diseases, neurodegenerative diseases, psoriasis, palmoplantar pustulosis, wrinkles, and severe acne
Classification Information
Class [005]
Pharmaceutical Products
Anticancer drugs; antitumor drugs; antineoplastic drugs; drugs for medical purposes, namely, Retinoic acid Receptor agonist for the treatment of autoimmune/inflammatory diseases, vascular diseases, neurodegenerative diseases, psoriasis, palmoplantar pustulosis, wrinkles, and severe acne
Mark Details
Serial Number
No 79034631
Mark Type
No Service/Collective Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 07th Jul 2017 | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED |
| 07th Jul 2017 | DEATH OF INTERNATIONAL REGISTRATION |
| 11th Sep 2015 | TOTAL INVALIDATION PROCESSED BY THE IB |
| 14th Aug 2015 | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB |
| 14th Aug 2015 | INVALIDATION PROCESSED |
| 17th Jun 2015 | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED |
| 20th Feb 2015 | NEW REPRESENTATIVE AT IB RECEIVED |
| 17th Oct 2014 | CANCELLED SECTION 71 |
| 12th Feb 2010 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| 12th Jun 2008 | FINAL DISPOSITION PROCESSED |